SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Amendment #2

Under the Securities and Exchange Act of 1934

 

 

Kiniksa Pharmaceuticals, Ltd

(Name of Issuer)

Class A Common Stock

(Title of Class of Securities)

G5269C101

(CUSIP Number)

December 31, 2021

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

This Schedule is filed pursuant to Rule 13d-1(b)

The information required in the remainder of this cover page (except any items to which the form provides a cross-reference) shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

 

 

 

---

CUSIP NO. G5269C101

 

1)		Name of Reporting Person     Ameriprise Financial, Inc.     S.S. or I.R.S. Identification No. of Above Person     IRS No. 13-3180631
2)		Check the Appropriate Box if a Member of a Group   (a)  ☐        (b)  ☒*
3)		SEC Use Only
4)		Citizenship or Place of Organization     Delaware

NUMBER OF SHARES  BENEFICIALLY  OWNED BY EACH REPORTING PERSON WITH				5)		Sole Voting Power     0
				6)		Shared Voting Power     285
				7)		Sole Dispositive Power     0
				8)		Shared Dispositive Power     285

9)		Aggregate Amount Beneficially Owned by Each Reporting Person     285
10)		Check if the Aggregate Amount in Row (9) Excludes Certain Shares     Not Applicable
11)		Percent of Class Represented by Amount In Row (9)     0.00%
12)		Type of Reporting Person     HC

 

*	This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

---

CUSIP NO. G5269C101

 

1)		Name of Reporting Person     Columbia Management Investment Advisers, LLC     S.S. or I.R.S. Identification No. of Above Person     IRS No. 41-1533211
2)		Check the Appropriate Box if a Member of a Group   (a)  ☐        (b)  ☒*
3)		SEC Use Only
4)		Citizenship or Place of Organization     Minnesota

NUMBER OF SHARES  BENEFICIALLY  OWNED BY EACH REPORTING PERSON WITH				5)		Sole Voting Power     0
				6)		Shared Voting Power     285
				7)		Sole Dispositive Power     0
				8)		Shared Dispositive Power     285

9)		Aggregate Amount Beneficially Owned by Each Reporting Person     285
10)		Check if the Aggregate Amount in Row (9) Excludes Certain Shares     Not Applicable
11)		Percent of Class Represented by Amount In Row (9)     0.00%
12)		Type of Reporting Person     IA

 

*	This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

---

CUSIP NO. G5269C101

 

1)		Name of Reporting Person     Columbia Wanger Asset Management, LLC     S.S. or I.R.S. Identification No. of Above Person     IRS No. 04-3519872
2)		Check the Appropriate Box if a Member of a Group   (a)  ☐        (b)  ☒*
3)		SEC Use Only
4)		Citizenship or Place of Organization     Delaware

NUMBER OF SHARES  BENEFICIALLY  OWNED BY EACH REPORTING PERSON WITH				5)		Sole Voting Power     0
				6)		Shared Voting Power     0
				7)		Sole Dispositive Power     0
				8)		Shared Dispositive Power     0

9)		Aggregate Amount Beneficially Owned by Each Reporting Person     0
10)		Check if the Aggregate Amount in Row (9) Excludes Certain Shares     Not Applicable
11)		Percent of Class Represented by Amount In Row (9)     0.00%
12)		Type of Reporting Person     IA

 

*	This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

---

CUSIP NO. G5269C101

 

1)		Name of Reporting Person     Columbia Acorn Fund     S.S. or I.R.S. Identification No. of Above Person     IRS No. 36-2692100
2)		Check the Appropriate Box if a Member of a Group   (a)  ☐        (b)  ☒*
3)		SEC Use Only
4)		Citizenship or Place of Organization     Massachusetts

NUMBER OF SHARES  BENEFICIALLY  OWNED BY EACH REPORTING PERSON WITH				5)		Sole Voting Power     0
				6)		Shared Voting Power     0
				7)		Sole Dispositive Power     0
				8)		Shared Dispositive Power     0

9)		Aggregate Amount Beneficially Owned by Each Reporting Person     0
10)		Check if the Aggregate Amount in Row (9) Excludes Certain Shares     Not Applicable
11)		Percent of Class Represented by Amount In Row (9)     0.00%
12)		Type of Reporting Person     IV

 

*	This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

---

1(a)		Name of Issuer:		Kiniksa Pharmaceuticals, Ltd
1(b)		Address of Issuer’s Principal		Clarendon House, 2 Church St.
		Executive Offices:		Hamilton HM11, Bermuda
2(a)		Name of Person Filing:		(a) Ameriprise Financial, Inc. (“AFI”)
				(b) Columbia Management Investment
				Advisers, LLC (“CMIA”)
				(c) Columbia Wanger Asset Management, LLC (“CWAM”)
				(d) Columbia Acorn Fund (“Fund”)
2(b)		Address of Principal Business Office:		(a) Ameriprise Financial, Inc.
				145 Ameriprise Financial Center
				Minneapolis, MN 55474
				(b) 290 Congress St.
				Boston, MA 02210
				(c) 71 S Wacker Drive, Suite 2500
				Chicago, IL 60606
				(d) 71 S Wacker Drive, Suite 2500
				Chicago, IL 60606
2(c)		Citizenship:		(a) Delaware
				(b) Minnesota
				(c) Delaware
				(d) Massachusetts
2(d)		Title of Class of Securities:		Class A Common Stock
2(e)		Cusip Number:		G5269C101

 

3	Information if statement is filed pursuant to Rules 13d-1(b) or 13d-2(b):

(a) Ameriprise Financial, Inc.

A parent holding company in accordance with Rule 13d-1(b)(1)(ii)(G). (Note: See Item 7)

(b) Columbia Management Investment Advisers, LLC

An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).

(c) Columbia Wanger Asset Management, LLC

An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).

(d) Columbia Acorn Fund

An investment company registered under Section 8 of the Investment Company Act.

---

4	Incorporated by reference to Items (5)-(9) and (11) of the cover page pertaining to each reporting person.

CMIA, CWAM and AFI do not directly own any shares of Common Stock of the issuer. As the investment adviser to the Fund and various other unregistered and registered investment companies and other managed accounts, CMIA and CWAM may be deemed to beneficially own the shares reported herein by the Fund. Accordingly, the shares reported herein by CMIA and CWAM include those shares separately reported herein by the Fund.

AFI, as the parent company of CMIA and CWAM, may be deemed to beneficially own the shares reported herein by those reporting persons. Accordingly, the shares reported herein by AFI include those shares separately reported herein by those reporting persons.

Each of AFI, CMIA and CWAM disclaims beneficial ownership of any shares reported on this Schedule.

 

5	Ownership of 5% or Less of a Class:

If this statement is being filed to report the fact as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following (X).

 

6	Ownership of more than 5% on Behalf of Another Person: Not Applicable

 

7	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:

AFI: See Exhibit I

 

8	Identification and Classification of Members of the Group:

Not Applicable

 

9	Notice of Dissolution of Group:

Not Applicable

 

10	Certification:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect.

---

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct.

Dated: February 14, 2022

 

---

Exhibit Index

 

Exhibit I		Identification and Classification of the Subsidiary which acquired the Security Being Reported on by the Parent Holding Company.
Exhibit II		Joint Filing Agreement

Exhibit I

to

Schedule 13G

Ameriprise Financial, Inc., a Delaware Corporation, is a parent holding company. The classification and identity of the relevant subsidiaries is as follows:

Investment Adviser – Columbia Management Investment Advisers, LLC is an investment adviser registered under section 203 of the Investment Advisers Act of 1940.

Investment Adviser – Columbia Wanger Asset Management, LLC is an investment adviser registered under section 203 of the Investment Advisers Act of 1940.

Exhibit II

to

Schedule 13G

Joint Filing Agreement

The undersigned persons agree and consent to the joint filing on their behalf of this Schedule 13G dated February 14, 2022 in connection with their beneficial ownership of Kiniksa Pharmaceuticals, Ltd. Each of Columbia Acorn Fund, Columbia Wanger Asset Management, LLC and Columbia Management Investment Advisers, LLC authorizes Ameriprise Financial, Inc. to execute the Schedule 13G to which this Exhibit is attached and make any necessary amendments thereto.

 

Ameriprise Financial, Inc.
By:		/s/ Michael G. Clarke
Name:		Michael G. Clarke
Title:		Senior Vice President, Head of Global Operations
Columbia Management Investment Advisers, LLC
By:		/s/ Michael G. Clarke
Name:		Michael G. Clarke
Title:		Senior Vice President, Head of Global Operations
Columbia Wanger Asset Management, LLC
By:		/s/ Joseph C. LaPalm
Name:		Joseph C. LaPalm
Title:		Chief Compliance Officer
Columbia Acorn Fund
By:		/s/ Joseph C. LaPalm
Name:		Joseph C. LaPalm
Title:		Vice President